Clinical Trial Update: Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction [NA]

View source ↗

Summary

An update on a clinical trial evaluating the GORE PV1 Device for pulmonary valve dysfunction in congenital heart defects, including Tetralogy of Fallot.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects
• Pulmonary Valve Insufficiency
• Pulmonary Valve Stenosis
• Tetralogy of Fallot

Drugs mentioned

• GORE PV1 Device

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Heart Defects, Congenital, Tetralogy of Fallot | NA | Status: ACTIVE_NOT_RECRUITING